Clinical Trial Update: Ifosfamide or Doxorubicin in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing ifosfamide versus doxorubicin in patients with advanced or metastatic soft tissue sarcoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Drugs mentioned

• Doxorubicin (Adriamycin) (doxorubicin)
• Ifosfamide (Ifex) (Ifosfamide)

Snippet

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC | Conditions: Sarcoma | Phase 3 | Status: COMPLETED